BPC-157 is an investigational peptide studied mainly in preclinical research. Evidence concerning its safety and efficacy in humans remains limited.

The Xeno Labs listing does not specify a concentration, dosage form, package quantity, or other formulation details. These should be verified from the manufacturer’s current product documentation.

FDA has noted limited safety information and potential immunogenicity and impurity concerns associated with BPC-157 preparations.